Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Results from the EMN-011 trial, combination therapy for multiple myeloma

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 13.12.18
Views: 366
Rating:

Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands

Prof Pieter Sonneveld speaks to ecancer at ASH 2018 about a clinical trail from the European Myeloma Network for newly diagnosed multiple myeloma, transplant eligible patients.

He outlines the study design and methods of the EMN-011 trial, and gives the first results from this.

Prof Sonneveld describes how this trial will impact clinical practise, with the follow up analysis occurring one year from now.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation